NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,455 | -46.2% | 63,290 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $30,601 | -26.6% | 63,290 | 0.0% | 0.00% | -40.0% |
Q1 2023 | $41,714 | -40.6% | 63,290 | 0.0% | 0.01% | -44.4% |
Q4 2022 | $70,252 | +49.5% | 63,290 | 0.0% | 0.01% | +50.0% |
Q3 2022 | $47,000 | – | 63,290 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
Virtu Financial LLC | 46,210 | $30 | 0.00% |
United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
UBS Group AG | 18,611 | $12,265 | 0.00% |
NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |